In-house Capabilities and Expertise

Our in-house Private Equity Team is dedicated to the Healthcare and Technology & Consumer sectors. Our deep know-how accumulated through years of working and investing into these fields equip us with unique insight and clear competitive advantage.

Private Equity

Healthcare

Private Equity

Technology & Consumer

Deal Sourcing Capabilities

Our in-house team is comprised of renowned industry and investment professionals with extensive deal sourcing and hands-on working experience.
Private Equity

Synergies within the Ecosystem

  • Resource support from VMS’s portfolio companies and founders
  • Referrals from public market and VMS’s venture capital partners

Industrial Resources from Core Partners

  • Extensive network of retail & services, and solid government and business relationships developed through years of operations and investments

Broad Network

  • Accumulated through VMS’s core team members’ 180+ years of investment experience
  • Combined 170 years of experience investing into healthcare and technology & consumer sectors
  • Our reputation and internal network enable direct access to over 1,000+ target companies on average per year

Credibility as an Investor

  • Supportive and value-add to help grow portfolio companies’ businesses

Industry Experience

  • Core team members have ample industry working experience, providing unique insights and able to foster stronger relationships, with portfolio companies and industry experts

Portfolio Company Highlights

Chime Biologics

Chime Biologics

A China-based and world-class Contract Development and Manufacturing Organization (CDMO).

Chime Biologics

A China-based and world-class Contract Development and Manufacturing Organization (CDMO).

CHIVD

CHIVD

A leading IVD company in China with next-generation diagnostic technology platform.

CHIVD

A leading IVD company in China with next-generation diagnostic technology platform.

Gamida Cell

Gamida Cell

A US-listed clinical stage cell therapy company which focuses on developing cell therapies to cure blood cancers and serious hematologic diseases.

Gamida Cell

A US-listed clinical stage cell therapy company which focuses on developing cell therapies to cure blood cancers and serious hematologic diseases.

I-Mab Biopharma

I-Mab Biopharma

A US-listed clinical-stage biopharmaceutical company which focuses on developing novel and highly differentiated biologics for cancer treatment.

I-Mab Biopharma

A US-listed clinical-stage biopharmaceutical company which focuses on developing novel and highly differentiated biologics for cancer treatment.

KingMed Diagnostics

KingMed Diagnostics

The largest independent clinical laboratory platform in China.

KingMed Diagnostics

The largest independent clinical laboratory platform in China.

New Horizon Health

New Horizon Health

A leading molecular diagnostic company which focuses on early cancer detection in China.

New Horizon Health

A leading molecular diagnostic company which focuses on early cancer detection in China.

Pharmaron

Pharmaron

A Hong Kong and China-listed R&D service provider for the life science industry.

Pharmaron

A Hong Kong and China-listed R&D service provider for the life science industry.

Profusa

Profusa

A biotech company which focuses on developing biocompatible sensors to measure different body analytes in the US.

Profusa

A biotech company which focuses on developing biocompatible sensors to measure different body analytes in the US.

Windtree Therapeutics

Windtree Therapeutics

A US-listed biopharmaceutical company with specialization in novel therapeutics.

Windtree Therapeutics

A US-listed biopharmaceutical company with specialization in novel therapeutics.

Zhaoke Ophthalmology

Zhaoke Ophthalmology

An ophthalmic specialized pharmaceutical company with a range of portfolio covering both anterior and posterior indications.

Zhaoke Ophthalmology

An ophthalmic specialized pharmaceutical company with a range of portfolio covering both anterior and posterior indications.

The above only shows selected portfolio companies VMS invested in.

error: